查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1999374

家庭輸液服務市場：2026-2032年全球市場預測（按服務類型、交付方式、給藥途徑、治療方法和最終用戶分類）

Home Infusion Services Market by Service Type, Delivery Mode, Route Of Administration, Therapy Type, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年家庭輸液服務市場價值為 263.2 億美元，預計到 2026 年將成長至 285.6 億美元，複合年成長率為 10.35%，到 2032 年將達到 524.9 億美元。

主要市場統計數據
基準年 2025 263.2億美元
預計年份：2026年 285.6億美元
預測年份：2032年 524.9億美元
複合年成長率 (%) 10.35%

簡要概述臨床進步、營運創新和支付方趨勢如何重塑家庭靜脈輸液在整個護理連續體中的作用。

隨著臨床實務日益複雜，護理模式也從傳統的醫院環境轉向患者家中，居家靜脈輸液服務的模式正在迅速變化。輸液療法的進步，以及靜脈輸液設備便攜性的提升和報銷管道的拓展，使得門診和居家靜脈及皮下輸液療法成為綜合患者照護中日益重要的組成部分。醫療服務提供者正在積極應對這一變化，調整其護理模式，在確保安全性、連續性和成本效益的同時，維持與機構護理同等的臨床績效標準。

數位醫療、小型輸液技術和監管調整將如何共同推動分散式輸液護理的模式轉移？

技術創新、監管調整和患者偏好的改變正在改變輸液治療的實施方式。居家照護不再是小眾選擇，而是逐漸成為減少住院次數、改善病患體驗的重要策略選擇。小型攜帶式輸液幫浦和皮下給藥技術的引入，以及病患教育和遠距臨床監測的改進，正在拓展可在院外安全進行的治療方法範圍。

美國關稅政策的演變對家庭輸液服務提供者和臨床項目的醫療設備和耗材供應鏈的累積營運影響。

2025年的關稅調整對整個輸液護理供應鏈都產生了影響，包括輸液幫浦、一次性用品和無菌配製原料的採購。進口醫療設備和原料關稅的提高，使得傳統上依賴全球製造地的醫療機構和供應商的採購流程變得更加複雜。因此，採購團隊正在重新審視其供應商組合和合約結構，以降低關稅相關的成本波動和交貨延遲帶來的風險。

關鍵細分洞察顯示管理方法、最終用戶環境、管理途徑、服務類型和治療類型如何共同塑造營運和臨床策略。

細分分析揭示了基於給藥方式、最終用戶、給藥途徑、服務類型和治療類別的不同操作和臨床考慮。給藥方式（靜脈注射與皮下注射）的差異會影響醫療設備的選擇、照護者的能力、監測強度。靜脈輸液治療通常需要更進階的監測，而皮下注射則允許更廣泛的門診給藥。不同最終用戶（診所、居家醫療和醫院）的差異導致了人員配備模式、認證程序和物流網路的差異，所有這些都必須進行調整以確保有效的護理過渡。

美洲、歐洲、中東和非洲以及亞太地區的機會和限制決定了部署管道和營運規模。

區域趨勢正在改變家庭靜脈輸液服務的引入和推廣方式，每個區域（美洲、歐洲、中東和非洲以及亞太地區）都面臨不同的促進因素和限制因素。在美洲，與門診報銷框架一致的監管環境以及完善的居家醫療基礎設施促進了靜脈輸液服務的快速普及，而人口老齡化和慢性病患病率的上升則持續推高了對門診治療的需求。相較之下，由於報銷體系和醫療服務結構的差異，歐洲、中東和非洲的情況則有所不同。一些國家優先發展集中式醫院服務，而另一些國家則正在嘗試利用遠端醫療和社區護理網路，建立分散式靜脈輸液管道。

策略夥伴關係、對認證的重視以及數位化如何影響靜脈輸液生態系統中企業的競爭差異化和能力發展？

家庭輸液生態系統的企業級發展趨勢以策略聯盟、能力差異化以及對臨床和供應鏈能力的定向投資為特徵。醫療服務提供者正與專科藥房、醫療設備製造商和技術供應商合作，建立整合式護理路徑，以減少交接環節並提高護理連續性。同時，擁有強大數位監測平台的新興參與企業正憑藉其主導數據分析的用藥依從性和安全性監測功能，為護理服務提供補充，從而迅速發展壯大。

領導者為確保家庭靜脈輸液服務的供應彈性、臨床能力和報銷系統的一致性而採用的實用營運和策略建議。

產業領導者應採取一系列切實可行的措施，在確保臨床標準和營運連續性的同時，最大限度地發揮分散式輸液的優勢。首先，領導者需要有系統地建立供應商多元化和近岸籌資策略，以減輕關稅造成的供應中斷。同時，他們應實施庫存管理框架，在不增加不必要資本負擔的情況下，維持臨床實務的可近性。其次，對人力資源發展的投入至關重要。臨床醫生和藥劑師需要標準化的能力發展計劃，涵蓋血管通路管理、輸液裝置操作和遠端分流通訊協定。

透過結合相關人員訪談、監管趨勢分析和交叉檢驗，採用高度透明的混合方法，可以獲得可靠的營運見解，用於輸液計畫。

本報告的調查方法融合了質性訪談、第二手資料整合和三角驗證，以確保獲得可靠且可操作的洞見。主要資訊透過對臨床醫生、藥房負責人、採購主管和居家醫療管理人員的結構化檢驗收集，以了解實際營運中的挑戰和策略重點。此外，還對監管指南、設備規格和專業標準進行了系統性審查，以確保臨床建議符合一般安全和品質預期。

此概要概述了永續家庭輸液護理實踐的未來前景，重點關注臨床卓越性、供應鏈韌性和數位監測的整合。

隨著臨床能力、數位化監測和病患偏好日益趨於一致，居家輸液服務將在現代醫療服務體系中發揮越來越重要的作用。其成功取決於醫療機構能否將無菌配製品質、護理專業知識和供應鏈韌性整合到符合支付方期望和監管標準的統一方案中。隨著相關人員接受分散式輸液管道，互通性、臨床醫生培訓以及對病人安全的重視程度，很可能決定哪些模式能夠有效且永續地擴展。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 工業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：家庭輸液服務市場：依服務類型分類

  • 藥局服務
  • 護理服務
  • 病患監測

第9章：家庭輸液服務市場：依交付方式分類

  • 靜脈
  • 皮下

第10章：家庭輸液服務市場：依給藥途徑分類

  • 中央靜脈
  • 周邊靜脈

第11章 家庭輸液服務市場：依治療方法

  • 抗生素滴注
    • Aminoglycosides
    • BETA-內醯胺
    • Fluoroquinolones
  • 腫瘤學
    • 靜脈注射抗癌藥物
    • 皮下注射抗癌藥物
  • 疼痛管理
    • 非鴉片類藥物輸注
    • 鴉片類藥物輸注
  • 腸外營養
    • 周邊靜脈營養
    • 全靜脈營養

第12章 家庭輸液服務市場：依最終用戶分類

  • 診所
  • 居家醫療護理
  • 醫院

第13章：家庭輸液服務市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 家庭輸液服務市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 家庭輸液服務市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國家庭輸液服務市場

第17章：中國家庭輸液服務市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Caesarea Medical Electronics Ltd.
  • CVS Health Corporation
  • Fresenius Kabi AG
  • ICU Medical, Inc.
  • InfuSystem Holdings, Inc.
  • JMS Co., Ltd.
  • Medtronic PLC
  • Moog Inc.
  • Nipro Corporation
  • Option Care Health, Inc.
  • Sichuan Consun Pharmaceutical Co., Ltd.
  • Terumo Corporation
Product Code: MRR-3A2E844FEC05

The Home Infusion Services Market was valued at USD 26.32 billion in 2025 and is projected to grow to USD 28.56 billion in 2026, with a CAGR of 10.35%, reaching USD 52.49 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 26.32 billion
Estimated Year [2026] USD 28.56 billion
Forecast Year [2032] USD 52.49 billion
CAGR (%) 10.35%

A concise orientation to how clinical advances, operational innovations, and payer dynamics are reshaping home infusion delivery across care continuums

The home infusion services landscape is evolving rapidly as clinical complexity shifts care beyond traditional inpatient settings and into patients' homes. Advances in infusion therapeutics, combined with enhanced portability of infusion devices and expanded reimbursement pathways, have made outpatient and home-based intravenous and subcutaneous therapies an increasingly viable component of comprehensive patient care. Providers are responding by reconfiguring care models to prioritize safety, continuity, and cost efficiency while maintaining clinical performance standards comparable to facility-based care.

As a result, stakeholders across clinical, operational, and payer communities are reassessing how infusion services are commissioned and delivered. Clinicians are integrating remote monitoring and telehealth to support nursing and medication administration workflows, whereas administrators are building partnerships with specialty pharmacies and compounding facilities to secure sterile preparations. Consequently, decision-makers must consider clinical competency, supply chain robustness, and regulatory compliance in parallel when designing scalable home infusion programs.

How digital health, compact infusion technologies, and regulatory adaptations collectively drive a paradigm shift toward decentralized infusion care

Care delivery for infusion therapies is undergoing transformative shifts as technological innovation, regulatory adjustments, and patient preferences converge. Home-based care is no longer a niche alternative; it is being embedded as a strategic option to reduce inpatient utilization and to improve patient experience. The adoption of compact ambulatory infusion pumps and subcutaneous administration techniques, alongside improvements in patient education and remote clinical oversight, has expanded the range of therapies that can be safely managed outside the hospital.

Meanwhile, regulatory frameworks are adapting to support decentralized care models, emphasizing quality metrics, safe compounding practices, and interoperability of clinical records. These shifts encourage integration between hospitals, outpatient clinics, and home healthcare entities and create incentives for care pathways that prioritize continuity and reduced readmission risk. In turn, healthcare leaders are investing in workforce training, digital monitoring, and process standardization to operationalize these transformative changes and to ensure consistent patient outcomes.

The cumulative operational consequences of evolving U.S. tariff policy on device and consumable supply chains for home infusion providers and clinical programs

Tariff policy adjustments in 2025 are creating ripples across supply chains that support infusion care, affecting procurement of infusion pumps, disposables, and sterile compounding inputs. Increased duties on imported medical devices and raw materials have raised sourcing complexity for providers and suppliers that historically relied on globalized manufacturing footprints. Consequently, procurement teams are reassessing vendor portfolios and contract structures to mitigate exposure to customs-related cost volatility and delivery delays.

In response, organizations are prioritizing supplier diversification, nearshoring of critical components, and strategic inventory buffering to maintain clinical continuity. Clinical leaders are collaborating with procurement and pharmacy stakeholders to validate alternative device options and to ensure compatibility with established clinical protocols. Over time, these adjustments are accelerating interest in domestic manufacturing partnerships and aggregated purchasing strategies that reduce transactional friction and support predictable supply flows for infusion services.

Critical segmentation insights that demonstrate how delivery mode, end user environment, administration route, service type, and therapy type jointly shape operational and clinical strategies

Segmentation analysis reveals differentiated operational and clinical considerations across delivery modes, end users, administration routes, service types, and therapy categories. Delivery mode distinctions between intravenous and subcutaneous pathways inform device selection, nursing competencies, and monitoring intensity, with intravenous therapies often requiring higher acuity oversight and subcutaneous options enabling broader outpatient administration. End user variation across clinics, home healthcare agencies, and hospitals translates to divergent staffing models, credentialing procedures, and logistical networks that must be coordinated for effective transitions of care.

Route of administration divides into central and peripheral approaches, shaping vascular access management, infection prevention protocols, and patient education priorities. Service types encompassing compounding services, nursing services, and patient monitoring form an integrated service architecture where sterile preparation quality feeds directly into nursing workflow efficiency and remote monitoring systems. Therapy-type groupings-antibiotic infusion, oncology, pain management, and parenteral nutrition-require therapy-specific clinical pathways; for example, antibiotic infusion spans aminoglycosides, beta-lactams, and fluoroquinolones with distinct pharmacokinetic and safety profiles, while oncology care differentiates between intravenous oncology agents and subcutaneous oncology agents, each presenting unique infusion scheduling and toxicity management needs. Pain management segregates into non-opioid and opioid infusion strategies, which necessitate different regulatory oversight and monitoring protocols, and parenteral nutrition splits into peripheral parenteral nutrition and total parenteral nutrition, each with distinct metabolic monitoring and catheter considerations.

Taken together, these segmentation dimensions inform how providers design clinical protocols, allocate capital for devices and compounding capacity, and structure care bundles that align with payer requirements and patient-centered outcomes. Consequently, stakeholders must tailor operational models and quality assurance mechanisms to the specific intersection of delivery mode, end user environment, administration route, service type, and therapy characteristics to ensure safe, efficient, and patient-focused infusion care.

Regional opportunities and constraints across the Americas, Europe Middle East & Africa, and Asia-Pacific that determine adoption pathways and operational scalability

Regional dynamics are reshaping how home infusion services are implemented and scaled, with distinct drivers and constraints across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, regulatory alignment with outpatient reimbursement frameworks and established home health infrastructures supports rapid uptake of infusion services, while population aging and chronic disease prevalence create sustained demand for ambulatory therapy delivery. Meanwhile, Europe, Middle East & Africa displays heterogeneity driven by divergent reimbursement regimes and healthcare delivery structures; some national systems prioritize centralized hospital services while others are piloting decentralized infusion pathways supported by telehealth and community nursing networks.

In Asia-Pacific, rapid development of domestic medical manufacturing, expansion of private healthcare providers, and growing investments in digital health platforms are enabling broader access to home-based infusion care, although variability in regulatory standards and workforce capacity can constrain uniform deployment. Across regions, differences in supply chain resilience, device approval timelines, and local compounding capabilities influence the speed and scale at which home infusion models can be integrated. Therefore, regional strategy must account for payer structures, workforce readiness, and regulatory alignment to successfully operationalize home infusion programs.

How strategic partnerships, accreditation focus, and digital enablement are shaping competitive differentiation and capability development among firms in the infusion ecosystem

Company-level dynamics in the home infusion ecosystem are characterized by strategic collaborations, capability differentiation, and targeted investments in clinical and supply chain capabilities. Providers are forming alliances with specialty compounding pharmacies, device manufacturers, and technology vendors to build integrated care pathways that reduce handoffs and improve continuity. At the same time, entrants with strong digital monitoring platforms are gaining traction by offering analytics-driven adherence and safety oversight that complement nursing services.

Competitive differentiation often centers on service breadth, compliance rigor, and the ability to deliver complex therapies with consistent clinical outcomes. Leaders prioritize accreditation, standardized compounding processes, and rigorous training programs to support higher-acuity home infusions. Additionally, firms that invest in interoperability with electronic health records and telehealth platforms enhance care coordination and reduce administrative friction. In sum, the corporate landscape favors organizations that can combine clinical excellence, supply chain resilience, and digital enablement to support a wide range of therapy types and care settings.

Actionable operational and strategic recommendations for leaders to secure supply resilience, clinical competency, and reimbursement alignment in home infusion services

Industry leaders should adopt a set of pragmatic actions to capitalize on decentralized infusion opportunities while safeguarding clinical standards and operational continuity. First, leaders must institutionalize supplier diversification and nearshore sourcing strategies to mitigate tariff-driven supply disruptions; simultaneously, they should implement inventory governance frameworks that preserve clinical access without creating unnecessary capital burden. Second, investment in workforce development is essential: clinicians and pharmacy staff require standardized competency programs that address vascular access management, infusion device operation, and remote triage protocols.

Moreover, organizations should prioritize integration of remote monitoring and telehealth into core service pathways to support earlier discharge and reduce readmission risk. Cross-functional governance that aligns clinical, pharmacy, and procurement functions will accelerate adoption of new therapies and devices while ensuring regulatory compliance. Finally, payers and providers should collaborate on reimbursement models that recognize the value of home infusion in patient-centered care, incentivizing outcomes-focused contracting and shared risk arrangements that reward quality and continuity of care.

Transparent mixed-methods approach combining stakeholder interviews, regulatory synthesis, and cross-validation to produce reliable operational insights for infusion programs

The research methodology underpinning this report integrates primary qualitative interviews, secondary document synthesis, and triangulated validation to ensure robust, actionable findings. Primary inputs were gathered through structured interviews with clinicians, pharmacy leaders, procurement executives, and home healthcare administrators to capture frontline operational challenges and strategic priorities. These insights were supplemented by a systematic review of regulatory guidance, device specifications, and professional standards to ensure clinical recommendations align with prevailing safety and quality expectations.

Analytical processes included cross-validation of interview themes with observed industry initiatives and public policy shifts, enabling identification of emergent patterns without relying on singular data sources. Throughout the process, careful attention was given to data provenance and potential bias mitigation, ensuring that findings reflect a balanced synthesis of stakeholder perspectives and documented practice. This blended methodology supports practical recommendations and a nuanced understanding of operational levers that influence successful deployment of home infusion services.

A forward-looking summary emphasizing integration of clinical excellence, supply chain resilience, and digital monitoring to operationalize sustainable home infusion care

Home infusion services are positioned to play an increasingly central role in modern care delivery as clinical capabilities, digital monitoring, and patient preferences continue to align. Success will depend on the ability of healthcare organizations to integrate sterile compounding quality, nursing competency, and supply chain resilience into coherent programs that meet payer expectations and regulatory standards. As stakeholders adopt decentralized infusion pathways, emphasis on interoperability, clinician training, and patient safety will determine which models scale effectively and sustainably.

Looking ahead, the convergence of device miniaturization, expanded subcutaneous therapy options, and remote oversight mechanisms will broaden the therapeutic scope suitable for home administration. Nevertheless, operational prudence-manifested as diversified sourcing, rigorous accreditation, and outcome-focused contracting-will remain essential to translating clinical potential into reliable, patient-centered care delivery.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Home Infusion Services Market, by Service Type

  • 8.1. Compounding Services
  • 8.2. Nursing Services
  • 8.3. Patient Monitoring

9. Home Infusion Services Market, by Delivery Mode

  • 9.1. Intravenous
  • 9.2. Subcutaneous

10. Home Infusion Services Market, by Route Of Administration

  • 10.1. Central
  • 10.2. Peripheral

11. Home Infusion Services Market, by Therapy Type

  • 11.1. Antibiotic Infusion
    • 11.1.1. Aminoglycosides
    • 11.1.2. Beta Lactams
    • 11.1.3. Fluoroquinolones
  • 11.2. Oncology
    • 11.2.1. Intravenous Oncology Agents
    • 11.2.2. Subcutaneous Oncology Agents
  • 11.3. Pain Management
    • 11.3.1. Non Opioid Infusion
    • 11.3.2. Opioid Infusion
  • 11.4. Parenteral Nutrition
    • 11.4.1. Peripheral Parenteral Nutrition
    • 11.4.2. Total Parenteral Nutrition

12. Home Infusion Services Market, by End User

  • 12.1. Clinics
  • 12.2. Home Healthcare Agencies
  • 12.3. Hospitals

13. Home Infusion Services Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Home Infusion Services Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Home Infusion Services Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Home Infusion Services Market

17. China Home Infusion Services Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. B. Braun Melsungen AG
  • 18.6. Baxter International Inc.
  • 18.7. Becton, Dickinson and Company
  • 18.8. Caesarea Medical Electronics Ltd.
  • 18.9. CVS Health Corporation
  • 18.10. Fresenius Kabi AG
  • 18.11. ICU Medical, Inc.
  • 18.12. InfuSystem Holdings, Inc.
  • 18.13. JMS Co., Ltd.
  • 18.14. Medtronic PLC
  • 18.15. Moog Inc.
  • 18.16. Nipro Corporation
  • 18.17. Option Care Health, Inc.
  • 18.18. Sichuan Consun Pharmaceutical Co., Ltd.
  • 18.19. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL HOME INFUSION SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL HOME INFUSION SERVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL HOME INFUSION SERVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES HOME INFUSION SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA HOME INFUSION SERVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL HOME INFUSION SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY COMPOUNDING SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY COMPOUNDING SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY COMPOUNDING SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY NURSING SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY NURSING SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY NURSING SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PATIENT MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PATIENT MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PATIENT MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY SUBCUTANEOUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY SUBCUTANEOUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY CENTRAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY CENTRAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY CENTRAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PERIPHERAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PERIPHERAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PERIPHERAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY AMINOGLYCOSIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY AMINOGLYCOSIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY AMINOGLYCOSIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY BETA LACTAMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY BETA LACTAMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY BETA LACTAMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY FLUOROQUINOLONES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY FLUOROQUINOLONES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY FLUOROQUINOLONES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY INTRAVENOUS ONCOLOGY AGENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY INTRAVENOUS ONCOLOGY AGENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY INTRAVENOUS ONCOLOGY AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY SUBCUTANEOUS ONCOLOGY AGENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY SUBCUTANEOUS ONCOLOGY AGENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY SUBCUTANEOUS ONCOLOGY AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY NON OPIOID INFUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY NON OPIOID INFUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY NON OPIOID INFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY OPIOID INFUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY OPIOID INFUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY OPIOID INFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PERIPHERAL PARENTERAL NUTRITION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PERIPHERAL PARENTERAL NUTRITION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PERIPHERAL PARENTERAL NUTRITION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY TOTAL PARENTERAL NUTRITION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY TOTAL PARENTERAL NUTRITION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY TOTAL PARENTERAL NUTRITION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY HOME HEALTHCARE AGENCIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY HOME HEALTHCARE AGENCIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY HOME HEALTHCARE AGENCIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. GCC HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. GCC HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. GCC HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 175. GCC HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 176. GCC HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. GCC HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 178. GCC HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 179. GCC HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 180. GCC HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 181. GCC HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 200. BRICS HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. G7 HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 203. G7 HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. G7 HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 205. G7 HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 206. G7 HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. G7 HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 208. G7 HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 209. G7 HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 210. G7 HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 211. G7 HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 212. NATO HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 213. NATO HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. NATO HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 215. NATO HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 216. NATO HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. NATO HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 218. NATO HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 219. NATO HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 220. NATO HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 221. NATO HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 222. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES HOME INFUSION SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED STATES HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED STATES HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 227. UNITED STATES HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. UNITED STATES HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 229. UNITED STATES HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 230. UNITED STATES HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 231. UNITED STATES HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 232. UNITED STATES HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 233. CHINA HOME INFUSION SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 234. CHINA HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. CHINA HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 236. CHINA HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 237. CHINA HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. CHINA HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 239. CHINA HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 240. CHINA HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 241. CHINA HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 242. CHINA HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)